BioSpace News Archive

DNAe announced that the US Food and Drug Administration has granted it a “Breakthrough Device” designation for its pioneering platform and first assay.

According to the report, the global X-ray market was valued at ~US$ 10.8 Bn in 2018 and is projected to expand at a CAGR of 5.5% from 2019 to 2027.

The report details an exhaustive account of the global ventilator accessories market along with numerous associated factors.

The demand in the global nanoparticles in biotechnology and pharmaceuticals market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications.

Heron Therapeutics, Inc. (Nasdaq: HRTX), , today announced that Barry Quart, Pharm.D., President and Chief Executive Officer of Heron Therapeutics, will present at the 19th Annual Needham Virtual Healthcare Conference on Tuesday, April 14th, 2020 at 2:50 p.m. ET.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2020 results after the financial markets close on Thursday, April 30, 2020

Retrophin, Inc. announced the appointment of Suzanne L. Bruhn, Ph.D. to the Company’s Board of Directors, effective immediately.

Conformis, Inc. announced that, due to the public health impact of the novel coronavirus outbreak and governmental restrictions limiting the number of people who may gather together, and to support the health and well-being of its stockholders, employees and communities, its 2020 annual meeting of stockholders, to be held on Monday, April 27, 2020 at 4:30 p.m. Eastern time, has been changed to a virtual meeting.

Simulations Plus, Inc., the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, reported financial results for its second quarter of fiscal year 2020, the period ended February 29, 2020.

Company to provide FDA-approved for EUA testing in its San Diego lab to assist physician clients in the fight against the coronavirus pandemic